Find the latest episode of "This Is Uncomfortable" here. Listen
Fast-Track Vaccines

Indian drugmaker says U.S. is hoarding vaccine ingredients

Scott Tong Mar 9, 2021
Heard on:
HTML EMBED:
COPY
The CEO of the Serum Institute of India said at a panel last Thursday that American raw materials are running out. Pictured: A Serum Institute employee works on an assembly line for the AstraZeneca vaccine. Punit Paranjpe/AFP via Getty Images
Fast-Track Vaccines

Indian drugmaker says U.S. is hoarding vaccine ingredients

Scott Tong Mar 9, 2021
Heard on:
The CEO of the Serum Institute of India said at a panel last Thursday that American raw materials are running out. Pictured: A Serum Institute employee works on an assembly line for the AstraZeneca vaccine. Punit Paranjpe/AFP via Getty Images
HTML EMBED:
COPY

COVID-19 vaccine manufacturers around the world are meeting today to discuss a looming supply chain problem: not enough raw materials and supplies to go around.

And among the countries accused of hoarding these items? The United States.

To speed up vaccine production, the Biden administration has invoked the Defense Production Act. The law, which dates back to World War II, lets government cut to the front of the customer line for critical items made by U.S. companies.

“This essentially enables the U.S. government to tell a supplier to ship the goods, in this case, to Johnson & Johnson,” said Simon Evenett, trade economist at the University of St. Gallen in Switzerland. “And those supplies, which were potentially destined to another customer, are of course then diverted.”

Unhappy customers bumped back in the queue include international vaccine makers, effectively blocking exports. The Serum Institute of India, the world’s largest vaccine producer, has contracts to produce the AstraZeneca and Novavax vaccines. CEO Adar Poonawalla said at a panel last Thursday that American raw materials are running out.

“There are a lot of bags and filters and critical items that manufacturers need,” Poonawalla said at the event, sponsored by the World Bank. “Now I’ll give you an example: the Novavax vaccine needs these items from the U.S.”

These items are being blocked from export due to Biden administration policy, he said. Marketplace asked the White House for comment, but did not hear back before deadline.

As the whole world ramps up vaccine production, key ingredients could run out.

“Unless production of what’s called the filling stage, as well as the syringes — unless this all scales up, too, there’s a potential for a problem,” Evenett said.

It’s true that the components in short supply are inexpensive, sometimes low-tech items. But until now, there’s been no business case to build more factories to crank them out.

“There’s no market and there’s no margin that will allow capacity to be built up over time,” said Krishna Udayakumar, associate director of the Duke Global Health Institute. “So we really have to invest in building that capacity.”

The looming vaccine material shortage presents the same dynamic as personal protective equipment and ventilator scarcity at the start of the pandemic: a surge in world demand, not enough to go around and countries wanting to keep supplies at home.

Still, Udayakumar defended the Biden administration’s decision to invoke the Defense Production Act for vaccines, allowing drugmaker Pfizer to potentially hit its production target of 2 billion doses by year’s end.

“That certainly is not just for the U.S.,” Udayakumar said. “That’s several times what the U.S. could use. So our ability to ramp up production will allow many other countries to also access those vaccines.”

Still, he said until vaccines are shared around the world, global trade and travel won’t be able to open up.

COVID-19 Economy FAQs

Can businesses deny you entry if you don’t have a vaccine passport?

As more Americans get vaccinated against COVID-19 and the economy begins reopening, some businesses are requiring proof of vaccination to enter their premises. The concept of a vaccine passport has raised ethical questions about data privacy and potential discrimination against the unvaccinated. However, legal experts say businesses have the right to deny entrance to those who can’t show proof.

Give me a snapshot of the labor market in the U.S.

U.S. job openings in February increased more than expected, according to the Labor Department. Also, the economy added over 900,000 jobs in March. For all of the good jobs news recently, there are still nearly 10 million people who are out of work, and more than 4 million of them have been unemployed for six months or longer. “So we still have a very long way to go until we get a full recovery,” said Elise Gould with the Economic Policy Institute. She said the industries that have the furthest to go are the ones you’d expect: “leisure and hospitality, accommodations, food services, restaurants” and the public sector, especially in education.

What do I need to know about tax season this year?

Glad you asked! We have a whole separate FAQ section on that. Some quick hits: The deadline has been extended from April 15 to May 17 for individuals. Also, millions of people received unemployment benefits in 2020 — up to $10,200 of which will now be tax-free for those with an adjusted gross income of less than $150,000. And, for those who filed before the American Rescue Plan passed, simply put, you do not need to file an amended return at the moment. Find answers to the rest of your questions here.

Read More

Collapse

Marketplace is on a mission.

We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.

Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?

Your donation is critical to the future of public service journalism. Support our work today – for as little as $5 – and help us keep making people smarter.